Clinical Trials Logo

Immunity, Cellular clinical trials

View clinical trials related to Immunity, Cellular.

Filter by:
  • None
  • Page 1

NCT ID: NCT03748524 Active, not recruiting - Immunity, Cellular Clinical Trials

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

Start date: October 29, 2018
Phase: Early Phase 1
Study type: Interventional

Immunization with the inactivated influenza vaccine with blood samples collected at 7 visits (baseline, day 7, 14, 28, 60, 90 and 180, fine needle aspiration (FNAs) from axillary lymph nodes at baseline, days, 4, 14, 28, 60 and 180. BMA at baseline, days 28 and 180.

NCT ID: NCT02560857 Completed - Immunity, Cellular Clinical Trials

Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients

QTF-Monitor
Start date: September 2014
Phase:
Study type: Observational

The study will prospectively determine the clinical utility of non-pathogen specific cellular immunity assessment using the Quantiferon-Monitor to quantify the degree of immunosuppression. The investigators will use the results of the assay to predict whether patients develop opportunistic infections and predict organ rejection.

NCT ID: NCT00241657 Completed - Immunity, Cellular Clinical Trials

Immune Responses to BCG Vaccination in Malawi and the UK

Start date: n/a
Phase: Phase 2
Study type: Interventional

BCG vaccination has been found to provide greater protection against TB in the UK than in Malawi. This study compares immune responses in BCG-vaccinated and unvaccinated teenagers and young adults in Malawi and in the UK.